Active Ingredient History
Resveratrol, a natural non-flavonoid polyphenol, exhibits a wide range of beneficial properties as an anticancer agent, a platelet anti-aggregation agent, and an antioxidant, as well as its anti-aging, anti-inflammatory, antiallergenic. This compound is in phase III clinical trials in combination with carboxymethyl-β-glucan for improving nasal symptoms in children with pollen-induced allergic rhinitis. Also in phase III clinical trial in the treatment of painful knee osteoarthritis and in type 2 diabetic patients. It has been demonstrated that resveratrol may prevent type 2 diabetic by targeting Sirtuin type 1 (SIRT1), indicating that SIRT1 may be a novel therapeutic target for diabetes prevention. NCATS
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acne Vulgaris (Phase 4)
Adenocarcinoma (Phase 1)
Aging (Phase 2)
Airway Extubation (Phase 2)
Alzheimer Disease (Phase 3)
Amyotrophic Lateral Sclerosis (Phase 2)
Androgens (Phase 3)
Antioxidants ()
Atherosclerosis (Phase 2)
Blood (Phase 1)
Bone Diseases (Phase 3)
Cardiomyopathy, Dilated (Phase 3)
Cardiovascular Diseases (Phase 2)
Colonic Neoplasms (Phase 1)
Colorectal Neoplasms (Phase 1)
Common Cold (Phase 3)
COVID-19 (Phase 2)
Depression (Phase 4)
Diabetes, Gestational (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Early Phase 1)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Nephropathies (Early Phase 1)
Drugs, Investigational (Phase 1)
Dyslipidemias (Phase 3)
Endometriosis (Phase 4)
Endothelial Cells (Phase 1/Phase 2)
Fertilization in Vitro (Phase 3)
Food-Drug Interactions (Phase 1)
Friedreich Ataxia (Phase 2)
Gastrointestinal Diseases (Phase 4)
Glucose Intolerance (Phase 1/Phase 2)
Gulf War (Phase 2)
Healthy Volunteers (Phase 1)
Heart Failure (Phase 2)
Huntington Disease (Phase 3)
Hypertension (Phase 1/Phase 2)
Infertility (Phase 3)
Inflammation (Phase 3)
Insulin Resistance (Phase 3)
Liver Neoplasms (Phase 1/Phase 2)
Lymphangioleiomyomatosis (Phase 2)
Lymphoma, Follicular (Phase 2)
Macular Degeneration (Phase 2)
Memory (Phase 1)
Metabolic Syndrome (Phase 3)
Mitochondrial Diseases (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 1)
Non-alcoholic Fatty Liver Disease (Phase 2/Phase 3)
Obesity (Phase 2/Phase 3)
Osteoarthritis, Knee (Phase 3)
Oxidation-Reduction (Phase 3)
Pancreatitis (Phase 4)
Parkinson Disease (Phase 1)
Periodontitis (Early Phase 1)
Peripheral Arterial Disease (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacological and Toxicological Phenomena (Early Phase 1)
Polycystic Ovary Syndrome (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 3)
Safety (Phase 1)
Schizophrenia (Phase 2)
Sedentary Behavior (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Spastic Paraplegia, Hereditary (Phase 2)
Sports Medicine (Phase 1)
Vascular Resistance (Phase 1/Phase 2)
Vascular Stiffness (Phase 1/Phase 2)
Vasodilation (Phase 1/Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue